Role of tissue factor in hemostasis, thrombosis, and vascular development
| [0004]
|
Defective thrombus formation in mice lacking factor XII
| [0005]
|
DX-88 and HAE: a developmental perspective
| [0006]
|
A mosquito salivary protein inhibits activation of the plasma contact system by binding to factor XII and high molecular weight kininogen
| [0006]
|
Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial
| [0008]
|
A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma
| [0010]
|
Hemostasis and Thrombosis. Basic principles & clinical practice
| [0010]
|
Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion
| [0010]
|
Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of FXII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction
| [0010]
|
The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: A study of prevalence in 21 patients and review of the literature
| [0010]
|
John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study
| [0010]
|
Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency - a study on 73 subjects from 14 Swiss families
| [0010]
|
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis
| [0011]
|
Infestin, a thrombin inhibitor present in Triatoma infestans midgut, a Chagas' disease vector: gene cloning, expression and characterization of the inhibitor
| [0012]
|
Identification and characterization of a novel factor XIIa inhibitor in the hematophagous insect, Triatoma infestans (Hemiptera: Reduviidae)
| [0012]
|
Strategies to improve plasma half-life time of peptide and protein drugs
| [0025]
|
Structure and evolution of human alpha-fetoprotein deduced from partial sequence of cloned cDNA
| [0035]
|
Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family
| [0035]
|
Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family
| [0035]
|
Protein inhibitors of proteinases
| [0041]
|
Nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine
| [0062]
|
Isolation and characterization of mutants constitutive for expression of the fbp1 gene of Schizosaccharomyces pombe
| [0062]
|
The production of recombinant pharmaceutical proteins in plants
| [0066]
|
Transgenic milk as a method for the production of recombinant antibodies
| [0067]
|
Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits
| [0067]
|
Transgenesis using nuclear transfer in goats
| [0067]
|
Pharmaceutical Formulation Development of Peptides and Proteins
| [0071]
|
Handbook of Pharmaceutical Excipients
| [0071]
|
Are hemostasis and thrombosis two sides of the same coin?
| [0080]
|